Echocardiography is the most widely used imaging to monitor cardiac functions, serving as the first line in early detection of myocardial ischemia and infarction. However, echocardiography often suffers from several artifacts including sensor noise, lack of contrast, severe saturation, and missing myocardial segments which severely limit its usage in clinical diagnosis. In recent years, several machine learning methods have been proposed to improve echocardiography views. Yet, these methods usually address only a specific problem (e.g. denoising) and thus cannot provide a robust and reliable restoration in general. On the other hand, cardiac MRI provides a clean view of the heart without suffering such severe issues. However, due to its significantly higher cost, it is often only afforded by a few major hospitals, hence hindering its use and accessibility. In this pilot study, we propose a novel approach to transform echocardiography into the cardiac MRI view. For this purpose, Echo2MRI dataset, consisting of echocardiography and real cardiac MRI image pairs, is composed and will be shared publicly. A dedicated Cycle-consistent Generative Adversarial Network (Cycle-GAN) is trained to learn the transformation from echocardiography frames to cardiac MRI views. An extensive set of qualitative evaluations shows that the proposed transformer can synthesize high-quality artifact-free synthetic cardiac MRI views from a given sequence of echocardiography frames. Medical evaluations performed by a group of cardiologists further demonstrate that synthetic MRI views are indistinguishable from their original counterparts and are preferred over their initial sequence of echocardiography frames for diagnosis in 78.9% of the cases.

Recent advancements in non-invasive detection of cardiac hemodynamic instability (CHDI) primarily focus on applying machine learning techniques to a single data modality, e.g. cardiac magnetic resonance imaging (MRI). Despite their potential, these approaches often fall short especially when the size of labeled patient data is limited, a common challenge in the medical domain. Furthermore, only a few studies have explored multimodal methods to study CHDI, which mostly rely on costly modalities such as cardiac MRI and echocardiogram. In response to these limitations, we propose a novel multimodal variational autoencoder ($\text{CardioVAE}_\text{X,G}$) to integrate low-cost chest X-ray (CXR) and electrocardiogram (ECG) modalities with pre-training on a large unlabeled dataset. Specifically, $\text{CardioVAE}_\text{X,G}$ introduces a novel tri-stream pre-training strategy to learn both shared and modality-specific features, thus enabling fine-tuning with both unimodal and multimodal datasets. We pre-train $\text{CardioVAE}_\text{X,G}$ on a large, unlabeled dataset of $50,982$ subjects from a subset of MIMIC database and then fine-tune the pre-trained model on a labeled dataset of $795$ subjects from the ASPIRE registry. Comprehensive evaluations against existing methods show that $\text{CardioVAE}_\text{X,G}$ offers promising performance (AUROC $=0.79$ and Accuracy $=0.77$), representing a significant step forward in non-invasive prediction of CHDI. Our model also excels in producing fine interpretations of predictions directly associated with clinical features, thereby supporting clinical decision-making.

Cardiac magnetic resonance imaging (MRI) has emerged as a clinically gold-standard technique for diagnosing cardiac diseases, thanks to its ability to provide diverse information with multiple modalities and anatomical views. Accelerated cardiac MRI is highly expected to achieve time-efficient and patient-friendly imaging, and then advanced image reconstruction approaches are required to recover high-quality, clinically interpretable images from undersampled measurements. However, the lack of publicly available cardiac MRI k-space dataset in terms of both quantity and diversity has severely hindered substantial technological progress, particularly for data-driven artificial intelligence. Here, we provide a standardized, diverse, and high-quality CMRxRecon2024 dataset to facilitate the technical development, fair evaluation, and clinical transfer of cardiac MRI reconstruction approaches, towards promoting the universal frameworks that enable fast and robust reconstructions across different cardiac MRI protocols in clinical practice. To the best of our knowledge, the CMRxRecon2024 dataset is the largest and most diverse publicly available cardiac k-space dataset. It is acquired from 330 healthy volunteers, covering commonly used modalities, anatomical views, and acquisition trajectories in clinical cardiac MRI workflows. Besides, an open platform with tutorials, benchmarks, and data processing tools is provided to facilitate data usage, advanced method development, and fair performance evaluation.

Heart failure is a serious and life-threatening condition that can lead to elevated pressure in the left ventricle. Pulmonary Arterial Wedge Pressure (PAWP) is an important surrogate marker indicating high pressure in the left ventricle. PAWP is determined by Right Heart Catheterization (RHC) but it is an invasive procedure. A non-invasive method is useful in quickly identifying high-risk patients from a large population. In this work, we develop a tensor learning-based pipeline for identifying PAWP from multimodal cardiac Magnetic Resonance Imaging (MRI). This pipeline extracts spatial and temporal features from high-dimensional scans. For quality control, we incorporate an epistemic uncertainty-based binning strategy to identify poor-quality training samples. To improve the performance, we learn complementary information by integrating features from multimodal data: cardiac MRI with short-axis and four-chamber views, and Electronic Health Records. The experimental analysis on a large cohort of $1346$ subjects who underwent the RHC procedure for PAWP estimation indicates that the proposed pipeline has a diagnostic value and can produce promising performance with significant improvement over the baseline in clinical practice (i.e., $\Delta$AUC $=0.10$, $\Delta$Accuracy $=0.06$, and $\Delta$MCC $=0.39$). The decision curve analysis further confirms the clinical utility of our method.

Cardiac MRI relaxometry is clinically used to quantitatively characterize various cardiovascular conditions, such as myocardial infarction (1), myocarditis (2), amyloidosis (3), and cardiomyopathy (4). Single-slice and multislice short-axis myocardial T1-mapping protocols have enabled quantification of global and local tissue alterations, including edema and fibrosis, across these pathologic states (5). Furthermore, precontrast (native) T1 (T1native) and postcontrast T1 (T1post) mapping can be combined to provide an estimate of extracellular volume (ECV). Clinically, T1 and ECV can be used to differentiate cardiac abnormality and potentially grade disease severity and risk stratification (6,7). Currently, the measurement of segmental myocardial T1 and ECV requires manual delineation of the left ventricle (LV) myocardium, LV blood pool, and right ventricular (RV) insertion point (RVIP) in both native and postcontrast T1 maps.

In recent years, cardiovascular diseases (CVDs) have become one of the leading causes of mortality globally. CVDs appear with minor symptoms and progressively get worse. The majority of people experience symptoms such as exhaustion, shortness of breath, ankle swelling, fluid retention, and other symptoms when starting CVD. Coronary artery disease (CAD), arrhythmia, cardiomyopathy, congenital heart defect (CHD), mitral regurgitation, and angina are the most common CVDs. Clinical methods such as blood tests, electrocardiography (ECG) signals, and medical imaging are the most effective methods used for the detection of CVDs. Among the diagnostic methods, cardiac magnetic resonance imaging (CMR) is increasingly used to diagnose, monitor the disease, plan treatment and predict CVDs. Coupled with all the advantages of CMR data, CVDs diagnosis is challenging for physicians due to many slices of data, low contrast, etc. To address these issues, deep learning (DL) techniques have been employed to the diagnosis of CVDs using CMR data, and much research is currently being conducted in this field. This review provides an overview of the studies performed in CVDs detection using CMR images and DL techniques. The introduction section examined CVDs types, diagnostic methods, and the most important medical imaging techniques. In the following, investigations to detect CVDs using CMR images and the most significant DL methods are presented. Another section discussed the challenges in diagnosing CVDs from CMR data. Next, the discussion section discusses the results of this review, and future work in CVDs diagnosis from CMR images and DL techniques are outlined. The most important findings of this study are presented in the conclusion section.

The advent of new field strengths of up to 10.5 Tesla allows magnetic resonance imaging in unprecedented detail. This opens up enormous opportunities in cardiac, neurological, and experimental medicine. Researchers will discuss these new possibilities at the MDC's Ultrahigh Field Magnetic Resonance Symposium on September 2 and 3. The use of magnetic resonance imaging (MRI) at 1.5 Tesla has long been a standard part of clinical practice. And about one in five major hospitals already has a 3-Tesla machine.

"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. To develop a convolutional neural network (CNN) solution for landmark detection in cardiac MRI. This retrospective study included cine, late-gadolinium enhancement (LGE), and T1 mapping scans from two hospitals.

"Artificial intelligence is moving out of the computer labs and into the real world of healthcare, carrying out some tasks better than doctors could do …

Doctors may be able to predict the chances of death, heart attack, and stroke in patients by using cardiac magnetic resonance imaging (MRI) paired with artificial intelligence (AI), potentially making treatment recommendations that will improve patient blood flow and outcomes. The study, conducted by researchers with University College London, was published Friday in the journal Circulation. It was the largest study of its kind to date. Investigators examined and compared the AI-generated blood flow results in patients collected from cardiac MRI scans to assess their risk for an adverse cardiac episode. This analysis showed patients with limited blood flow were more likely to experience negative heart-related outcomes.